Standard BioTools (LAB) EBITDA (2010 - 2026)
Standard BioTools (LAB) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Standard BioTools (LAB) EBITDA is -$90M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Standard BioTools (LAB) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +5.31% |
| 3 Years TTM | +29.92% |
| 5 Years TTM | +11.59% |
| 10 Years TTM | +5.87% |
| All Time TTM | +12.88% |
Annual EBITDA change of Standard BioTools (LAB)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$11M | -89.26% |
| 2025 | -$103M | -10.27% |
| 2024 | -$115M | +80.17% |
| 2023 | -$64M | -38.38% |
| 2022 | -$104M | +61.50% |
| 2021 | -$64M | +34.00% |
| 2020 | -$48M | -0.62% |
| 2019 | -$48M | +9.74% |
| 2018 | -$44M | -16.20% |
| 2017 | -$52M | -22.95% |
| 2016 | -$68M | +46.27% |
| 2015 | -$47M | -4.69% |
| 2014 | -$49M | +198.35% |
| 2013 | -$16M | -10.35% |
| 2012 | -$18M | -4.90% |
| 2011 | -$19M | +30.97% |
| 2010 | -$15M | -10.06% |
| 2009 | -$16M | N/A |
Comparison Standard BioTools (LAB) five years EBITDA CAGR with competitors
Standard BioTools (LAB) five years EBITDA CAGR is 11.58%.